Bristol-Myers Squibb Co.

NYS : BMY
Pharmaceuticals
New York NY
IW Best50N/A
2012 Revenue (US$ Millions)$17,621
2011 Revenue (US$ Millions)$21,244
Revenue Growth (%)-17.05%
Net Income (US$ Millions)$1,960
Common Shares Outstanding (Millions)$1,630
Earnings Per Share (US$)$1.16
Total Equity (US$ Millions)$13,623
Profit Growth (%)-47.16
Profit Margin (%)11.12%
Return On Equity (%)12.28%
Long Term Debt (US$ Millions)$6,568
Debt To Equity Ratio (%)0.48%
Market Capitalization (US$ Millions)$53,122
Total Assets (US$ Millions)$35,897
Return on Assets (%)5.94
Current Assets (US$ Millions)$9,521
Inventories (US$ Millions)$1,657
Current Liabilities (US$ Millions)$8,279
Cost of Goods Sold (US$ Millions)$4,610
Asset Turnover0.49
Inventory Turnover3.03